COMP <GO>
SCLX vs UNH // DIVIDEND YIELD & FCF PAYOUT SAFETY
Scilex Holding Company (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: SCLX 2
— UNH 8
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: UNH
LAST: $1.85 (-1.07%) • MKT CAP: $15.9M
dividend-safety
0.00%
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
dividend-safety
2.29%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SCLX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SCLX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 88.31% | +7.69 | SCLX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 12.38% | -47.38 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 21.05% | 6.25% | +14.80 | SCLX | /fcf-yield <GO> |
| Operating Margin | -60.00% | 5.32% | -65.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.53% | -63.53 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -46.50% | 3.33% | -49.83 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.09 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 21.7 | 55.1 | -33.40 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.9M | $359.43B | -$359.42B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SCLX REV | UNH REV | SCLX GROSS % | UNH GROSS % | SCLX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $30.3M | $447.57B | 98.0% | 88.7% | $3.7M | $16.07B |
| FY 2024 | $56.6M | $400.28B | 98.0% | 88.3% | $19.3M | $20.70B |
| FY 2023 | $46.7M | $371.62B | — | 89.6% | -$20.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SCLX // BETA —
UNH // BETA 0.33